Literature DB >> 12657316

Inhibition of brevetoxin binding to the voltage-gated sodium channel by gambierol and gambieric acid-A.

Masayuki Inoue1, Masahiro Hirama, Masayuki Satake, Kiminori Sugiyama, Takeshi Yasumoto.   

Abstract

Brevetoxins (BTXs) and ciguatoxins (CTXs) bind to site 5 of the voltage-gated sodium channel of excitable membranes. In the present study, we performed a competitive inhibition assay with other structurally distinct naturally occurring polyethers using isotope-labeled dihydro BTX-B ([3H]PbTx-3), which showed, for the first time, that gambierol and gambieric acid-A inhibit the binding of [3H]PbTx-3 while yessotoxins are inactive in this assay. The inhibition assay also suggested that there is a significant relationship between the size of the polycyclic region and inhibitory activity. Interestingly, the acute mouse toxicities of the compounds do not correspond directly to their inhibitory activities. These observations will serve as a guide for designing artificial polyethers with desired activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657316     DOI: 10.1016/s0041-0101(02)00369-0

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  20 in total

1.  A new polyether ladder compound produced by the dinoflagellate Karenia brevis.

Authors:  Andrea J Bourdelais; Henry M Jacocks; Jeffrey L C Wright; Paul M Bigwarfe; Daniel G Baden
Journal:  J Nat Prod       Date:  2005-01       Impact factor: 4.050

2.  Influence of lipid-soluble gating modifier toxins on sodium influx in neocortical neurons.

Authors:  Zhengyu Cao; Joju George; William H Gerwick; Daniel G Baden; Jon D Rainier; Thomas F Murray
Journal:  J Pharmacol Exp Ther       Date:  2008-04-30       Impact factor: 4.030

3.  Gambierol inhibition of voltage-gated potassium channels augments spontaneous Ca2+ oscillations in cerebrocortical neurons.

Authors:  Zhengyu Cao; Yanjun Cui; Eric Busse; Suneet Mehrotra; Jon D Rainier; Thomas F Murray
Journal:  J Pharmacol Exp Ther       Date:  2014-06-23       Impact factor: 4.030

4.  Two-directional olefinic-ester ring-closing metathesis using reduced Ti alkylidenes. A rapid entry into polycyclic ether skeletons.

Authors:  Yuan Zhang; Jon D Rainier
Journal:  Org Lett       Date:  2009-01-01       Impact factor: 6.005

5.  First- and second-generation total synthesis of ciguatoxin CTX3C.

Authors:  Masayuki Inoue; Keisuke Miyazaki; Hisatoshi Uehara; Megumi Maruyama; Masahiro Hirama
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-15       Impact factor: 11.205

6.  A quantitative and comparative study of the effects of a synthetic ciguatoxin CTX3C on the kinetic properties of voltage-dependent sodium channels.

Authors:  Kaoru Yamaoka; Masayuki Inoue; Hidemichi Miyahara; Keisuke Miyazaki; Masahiro Hirama
Journal:  Br J Pharmacol       Date:  2004-06-14       Impact factor: 8.739

7.  Brevenal is a natural inhibitor of brevetoxin action in sodium channel receptor binding assays.

Authors:  Andrea J Bourdelais; Susan Campbell; Henry Jacocks; Jerome Naar; Jeffery L C Wright; Jigani Carsi; Daniel G Baden
Journal:  Cell Mol Neurobiol       Date:  2004-08       Impact factor: 5.046

8.  A polyether biotoxin binding site on the lipid-exposed face of the pore domain of Kv channels revealed by the marine toxin gambierol.

Authors:  Ivan Kopljar; Alain J Labro; Eva Cuypers; Henry W B Johnson; Jon D Rainier; Jan Tytgat; Dirk J Snyders
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-29       Impact factor: 11.205

9.  Gambierol, a toxin produced by the dinoflagellate Gambierdiscus toxicus, is a potent blocker of voltage-gated potassium channels.

Authors:  Eva Cuypers; Yousra Abdel-Mottaleb; Ivan Kopljar; Jon D Rainier; Adam L Raes; Dirk J Snyders; Jan Tytgat
Journal:  Toxicon       Date:  2008-01-12       Impact factor: 3.033

Review 10.  Phytoplankton Toxins and Their Potential Therapeutic Applications: A Journey toward the Quest for Potent Pharmaceuticals.

Authors:  Biswajita Pradhan; Jang-Seu Ki
Journal:  Mar Drugs       Date:  2022-04-18       Impact factor: 6.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.